ZH
RU
ES

Drugs on the market in recent years

Drugs on the market in recent years, Total:133 items.

In the international standard classification, Drugs on the market in recent years involves: Buildings, Medical sciences and health care facilities in general, Pharmaceutics, Test conditions and procedures in general, HEALTH CARE TECHNOLOGY.

US-CFR-file, Drugs on the market in recent years

CFR 21-822.15-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.15:How long must I conduct postmarket surveillance of my device?
CFR 21-822.7-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.7:What should I do if I do not agree that postmarket surveillance is appropriate?
CFR 21-814.3-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.3:Definitions.
CFR 21-814.84-2013 Food and Drugs. Part814:Premarket approval of medical devices. Section814.84:Reports.
CFR 21-814.20-2013 Food and Drugs. Part814:Premarket approval of medical devices. Section814.20:Application.
CFR 21-814.39-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.39:PMA supplements.
CFR 21-73.530-2013 Food and Drugs. Part73:Listing of color additives exempt from certification. Section73.530:Spirulina extract.
CFR 21-814.100-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.100:Purpose and scope.
CFR 21-814.116-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.116:Procedures for review of an HDE.
CFR 21-814.44-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.44:Procedures for review of a PMA.
CFR 21-814.104-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.104:Original applications.
CFR 21-822.3-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.3:How do you define the terms used in this part?
CFR 21-822.9-2013 Food and Drugs. Part822:Postmarket surveillance. Section822.9:What must I include in my submission?
CFR 21-814.37-2014 Food and Drugs. Part814:Premarket approval of medical devices. Section814.37:PMA amendments and resubmitted PMAs.
CFR 21-73.350-2013 Food and Drugs. Part73:Listing of color additives exempt from certification. Section73.350:Mica-based pearlescent pigments.
CFR 21-73.3106-2013 Food and Drugs. Part73:Listing of color additives exempt from certification. Section73.3106:1,4-Bis[4-(2- methacryloxyethyl) phenylamino]anthraquinone co-polymers.
CFR 21-73.3100-2013 Food and Drugs. Part73:Listing of color additives exempt from certification. Section73.3100:1,4-Bis[(2-hydroxyethyl)amino]-9,10-anthracenedione bis(2-methyl-2-propenoic)ester co-polymers.

Group Standards of the People's Republic of China, Drugs on the market in recent years

T/SZCC 001-2023 Shenzhen biomedicine Industry "industrial upstairs"Design guidelines

IX-EU/EC, Drugs on the market in recent years

2007/C 144/06-2007 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 May 2007 to 31 May 2007
2008/C 188/04-2008 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 June 2008 to 30 June 2008
2012/C 107/08 CORR-2012 Corrigendum to the summary of Community decisions on marketing authorizations in respect of medicinal products from 1 December 2007 to 31 December 2007 (Official Journal of the European Union C 19 of 25 January 2008)
2007/C 266/06-2007 Medicinal products - List of marketing authorisations granted by the EEA EFTA States for the second half of 2006 Subcommittee I - On the free movement of goods
2012/C 401/02-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2012 to 30 November 2012 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the
2012/C 94/01-2012 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2012 to 29 February 2012 (Published pursuant to Art
2012/C 371/01-2012 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2012 to 31 August 2012 (Published pursuant to Article
2013/C 250/01-2013 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2013 to 28 February 2013 (Decisions taken pursuant
2013/C 282/01-2013 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2013 to 31 August 2013 (Published pursuant to Article
2014/C 467/01-2014 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2014 to 30 November 2014 (Published pursuant to Art
2015/C 361/01-2015 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 September 2015 to 30 September 2015 (Published pursuant to A
2015/C 032/01-2015 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 December 2014 to 31 December 2014 (Published pursuant to Art
2012/C 371/02-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2012 to 31 August 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
87/22/EEC-1986 Council Directive on the Approximation of National Measures Relating to the Placing on the Market of High- Technology Medicinal Products, Particularly Those Derived from Biotechnology
2012/C 78/01-2012 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 January 2012 to 31 January 2012 (Published pursuant to Artic
2013/C 24/01-2013 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 December 2012 to 31 December 2012 (Published pursuant to Art
2013/C 380/1-2013 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2013 to 30 November 2013 (published pursuant to Art
2014/C 29/01-2014 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 December 2013 to 31 December 2013 (Published pursuant to Art
2015/C 396/01-2015 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2015 to 31 October 2015 (Published pursuant to Artic
2012/C 56/02-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2011 to 31 December 2011 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2012/C 224/02-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2012 to 30 June 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2012/C 264/02-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2012 to 31 July 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2012/C 328/02-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 September 2012 to 30 September 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2012/C 371/03-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2012 to 31 October 2012 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Co
2013/C 24/02-2013 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 December 2012 to 31 December 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2013/C 53/01-2013 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1?October 2012 to 31?October 2012 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Co
2013/C 184/02-2013 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2013 to 31 May 2013 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2013/C 282/02-2013 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2013 to 31 August 2013 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2013/C 380/02-2013 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2013 to 30 November 2013 (decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2014/C 428/02-2014 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2014 to 31 October 2014 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2014/C 29/02-2014 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 December 2013 to 31 December 2013 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2014/C 243/02-2014 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2014 to 30 June 2014 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2014/C 290/02-2014 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2014 to 31 July 2014 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2014/C 467/02-2014 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2014 to 30 November 2014 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2014/C 123/02-2014 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2014 to 31 March 2014 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2014/C 165/02-2014 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 April 2014 to 30 April 2014 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2015/C 148/03-2015 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2015 to 31 March 2015 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2015/C 032/02-2015 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 December 2014 to 31 December 2014 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2007/C 288/04-2007 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 October 2007 to 31 October 2007
2012/C 190/01-2012 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2012 to 31 May 2012 (Published pursuant to Article 13 or
2013/C 184/01-2013 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2013 to 31 May 2013 (Published pursuant to Article 13 or
2014/C 123/01-2014 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2014 to 31 March 2014 (Published pursuant to Article 1
2014/C 337/01-2014 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2014 to 31 July 2014 (Published pursuant to Article 13
2014/C 199/01-2014 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2014 to 31 May 2014 (Published pursuant to Article 13 or
2014/C 243/01-2014 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2014 to 30 June 2014 (Published pursuant to Article 13
2014/C 290/01-2014 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2014 to 31 July 2014 (Published pursuant to Article 13
2014/C 165/01-2014 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 April 2014 to 30 April 2014 (Published pursuant to Article 1
2015/C 211/01-2015 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2015 to 31 May 2015 (Published pursuant to Article 13 or
2014/C 337/02-2014 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 August 2014 to 31 August 2014 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Coun
2015/C 396/02-2015 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2015 to 31 October 2015 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2))
2015/C 148/02-2015 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2015 to 31 March 2015 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Counci
93/41/EEC-1993 Council Directive Repealing Directive 87/22/EEC on the Approximation of National Measures Relating to the Placing on the Market of High- Technology Medicinal Products, Particularly Those Derived from Biotechnology
2007/C 316/07-2007 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 October 2007 to 31 October 2007
2008/C 188/05-2008 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 June 2008 to 30 June 2008
2013/C 154/02-2013 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 30 April 2013 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2013/C 311/02-2013 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 30 September 2013 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2013/C 154/03-2013 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 January to 31 January 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2008/31/EC-2008 DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL amending Directive 98/8/EC concerning the placing of biocidal products on the market, as regards the implementing powers conferred on the Commission
NO 1451/2007-2007 COMMISSION REGULATION on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)
2013/C 311/01-2013 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 30 September 2013 (Published pursuant to Article 13 or 38
2014/C 428/01-2014 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 31 October 2014 (published pursuant to Article 13 or 38 o
2015/C 148/01-2015 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 28 February 2015 (Published pursuant to Article 13 or 38
2016/C 116/01-2016 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 29 February 2016 (Published pursuant to Article 13 or 38
2013/C 154/01-2013 NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 to 30 April 2013 (Published pursuant to Article 13 or 38 of

RU-GOST R, Drugs on the market in recent years

GOST R 56701-2015 Medicines for medical applications. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals

US-FCR, Drugs on the market in recent years

FCR 21 CFR PART 99-2015 DISSEMINATION OF INFORMATION ON UNAPPROVED/ NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES
FCR 21 CFR PART 99-2013 DISSEMINATION OF INFORMATION ON UNAPPROVED/ NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES

EU/EC - European Union/Commission Legislative Documents, Drugs on the market in recent years

2009/C 146/03-2009 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 May 2009 to 31 May 2009 — Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted (Published pursuant to Article 13 or Ar
2009/C 146/04-2009 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 May 2009 to 31 May 2009 — Issuing@ maintenance or modification of a national marketing authorisation (Decisions taken pursuant to Article 34 of Directive 20
2016/C 312/03 CORR-2016 Corrigendum to Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2016 to 31 March 2016 (Official Journal of the European Union C 154 of 29 April 2016)
2016/C 076/01-2016 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 January 2016 to 31 January 2016 (Published pursuant to Artic
2016/C 399/01-2016 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 September 2016 to 30 September 2016 (Published pursuant to A
2017/C 367/01-2017 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 September 2017 to 30 September 2017 (Published pursuant to A
2012/C 328/01-2012 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 September 2012 to 30 September 2012 (Published pursuant to Article 13 or Article
2017/C 102/01-2017 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2017 to 28 February 2017 (Published pursuant to Art
2016/C 438/01-2016 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2016 to 31 October 2016 (Published pursuant to Artic
2017/C 028/01-2017 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 December 2016 to 31 December 2016 (Published pursuant to Art
2015/C 176/01-2015 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2015 to 28 February 2015 (Published pursuant to Art
2012/C 56/01-2012 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2011 to 31 December 2011 (Published pursuant to Art
2017/C 367/02-2017 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 September 2017 to 30 September 2017 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2016/C 312/02-2016 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2016 to 31 July 2016 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC)
2016/C 399/02-2016 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 September 2016 to 30 September 2016 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2017/C 028/02-2017 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 December 2016 to 31 December 2016 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2012/C 401/01-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2012 to 31 October 2012 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Co
2012/C 190/02-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 May 2012 to 31 May 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2012/C 371/04-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2012 to 31 October 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2011/C 383/02-2011 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 September 2011 to 31 October 2011 ((Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC))
2015/C 176/03-2015 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 April 2015 to 30 April 2015 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2))
2017/C 135/02-2017 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2017 to 31 March 2017 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2009/C 260/04-2009 Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 September 2009 to 30 September 2009 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Cou
2011/C 184/02-2011 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2011 to 30 April 2011 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2012/C 78/02-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 January 2012 to 31 January 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2016/C 277/02-2016 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2016 to 30 June 2016 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2))
2016/C 076/02-2016 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 January 2016 to 31 January 2016 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2012/C 401/03-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 November 2012 to 30 November 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2012/C 94/02-2012 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2012 to 29 February 2012 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
2017/C 245/01-2017 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2017 to 30 June 2017 (Published pursuant to Article 13
2017/C 135/01-2017 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2017 to 31 March 2017 (Published pursuant to Article 1
2016/C 312/01-2016 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2016 to 31 July 2016 (Published pursuant to Article 13
2011/C 383/01-2011 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 September 2011 to 31 October 2011 (Published pursuant to Art
2016/C 277/01-2016 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2016 to 30 June 2016 (Published pursuant to Article 13
2009/C 48/04-2009 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 January 2009 to 31 January 2009 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
2009/C 48/05-2009 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 January 2009 to 31 January 2009 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2))
2010/C 22/02-2010 Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 November 2009 to 30 November 2009 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Counc
2015/C 176/02-2015 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 April 2015 to 30 April 2015 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Counci
2009/C 73/03-2009 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 February 2009 to 28 February 2009 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Counc
2009/C 73/04-2009 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 February 2009 to 28 February 2009 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2))
2010/C 22/04-2010 Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 December 2009 to 31 December 2009 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Counc
2017/C 102/02-2017 Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2017 to 28 February 2017 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC (1) or Article 38 of Directive 2001/82/EC (2))
2009/C 231/03-2009 Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 July 2009 to 31 July 2009 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)
2012/C 264/01-2012 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 July 2012 to 31 July 2012 (Published pursuant to Article 13 or Article 38 of Reg
2012/C 224/01-2012 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 June 2012 to 30 June 2012 (Published pursuant to Article 13 or Article 38 of Reg
2016/C 154/01-2016 NOTICES FROM EUROPEAN UNION INSTITUTIONS@ BODIES@ OFFICES AND AGENCIES EUROPEAN COMMISSION Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2016 to 31 March 2016 (2016/C 154/01; Published pursua
2009/C 231/04-2009 Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 July 2009 to 31 July 2009 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council or Article 38 of Dir
2009/C 231/06-2009 Summary of Community decisions on marketing authorisations in respect of medicinal products from 1 August 2009 to 31 August 2009 (Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council or Article 38 of